W. R. Berkley Corporation WRB SPXR3KFINANCIAL
Company Overview
W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide. The company operates through Insurance and Reinsurance & Monoline Excess segments. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines. This segment also provides accident and health insurance and reinsurance products; insurance for commercial risks; casualty and specialty environmental products; insurance coverages for fine arts and jewelry exposures; excess liability and inland marine coverage for small to medium-sized insureds; and commercial general liability, umbrella, professional liability, directors and officers, commercial property, and surety products, as well as products for technology, and life sciences and travel industries. In addition, it offers cyber risk solutions; crime and fidelity insurance products; medical professional coverages; workers' compensation insurance products; management liability and general insurance products; personal lines insurance solutions, including home, condo/co-op, auto, fine arts and collectibles, liability, collector vehicle, and recreational marine; law enforcement, public officials and educator's legal, and employment practices liability, as well as incidental medical, property, and crime insurance products; at-risk and alternative risk insurance program management services; professional liability; energy and marine risks; and insurance products to the Lloyd's marketplace. The Reinsurance & Monoline Excess segment provides treaty and facultative reinsurance solutions; property and casualty reinsurance products; facultative reinsurance products include automatic, semi-automatic, and individual risk assumed reinsurance; and turnkey products, such as cyber, employment practices liability insurance, liquor liability insurance and violent events. The company was founded in 1967 and is headquartered in Greenwich, Connecticut.
Why Investors Should Care
Generates a return on equity of 20.2%, reflecting efficient use of shareholder capital.
Net profit has compounded at 12.2% per year over the last five years.
Trades at a P/E of 14.3, below the sector median of 14.5.
Operating margin of 16.4% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.32.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $14.64B (+6.9% YoY); net profit $1.78B.
- Trailing 12 Months Year-on-year growth — revenue +1.2%, earnings +15.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 7.3%, profit CAGR 12.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 7.35% |
| 1 Year: | 1.20% |
Compounded Profit Growth
| 5 Years: | 12.22% |
| 1 Year: | 15.00% |
Stock Price Performance
| 1 Year: | +0.19% |
| 6 Months: | +0.38% |
| 3 Months: | +2.36% |
| 1 Month: | -3.56% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)49.21 · Neutral
P/E of 14.31 is below the sector median of 14.52 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 20.2%.
- Profit CAGR of 12.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | WRB W. R. Berkley Corporation SPXR3KFINANCIAL | 69.56 | 14.31 | $25.82B | 0.55% | - | 20.21% | 7.35% | 12.22% |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 358.64 | 15.37 | $953.34B | 1.68% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 506.03 | 15.07 | $707.59B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 374.00 | 31.86 | $637.34B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 579.21 | 31.82 | $503.60B | 0.60% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.68 | 14.48 | $438.31B | 2.03% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 759,350.00 | 15.07 | $384.00B | 0.00% | - | 10.50% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 107.11 | 15.30 | $367.34B | 3.62% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 217.72 | 17.59 | $342.26B | 2.15% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.79B | 1.86B | 1.81B | 1.81B | 1.86B | 2.02B | 1.97B | 1.87B | 1.85B | 2.03B | 1.93B | 1.89B | 1.91B | 1.94B | 1.95B | 1.94B | 2.02B | 1.97B | 1.98B | 1.81B | 1.94B | 2.04B | 2.16B | 2.30B | 2.42B | 2.92B | 2.51B | 2.72B | 2.90B | 3.00B | 3.03B | 3.26B | 3.31B | 3.40B | 3.53B | 3.62B | 3.78B | 3.72B | 3.71B | 3.72B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 570.33M | 553.64M | 679.87M | 603.59M | 647.81M | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.73M | 31.78M | 31.76M | 31.63M | 31.71M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 538.61M | 521.86M | 648.11M | 571.96M | 616.10M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 121.26M | 121.16M | 136.14M | 117.21M | 100.52M | - |
| Net Income | 123.03M | 152.61M | 109.75M | 119.51M | 108.97M | 220.65M | 152.79M | 123.45M | 109.00M | 162.05M | 154.59M | 166.40M | 180.07M | 161.92M | 132.36M | 180.72M | 216.71M | 165.21M | 119.31M | -4.42M | 71.26M | 151.68M | 229.53M | 237.24M | 261.30M | 590.64M | 179.32M | 228.88M | 294.13M | 356.31M | 333.59M | 442.47M | 371.91M | 365.63M | 417.57M | 401.29M | 511.03M | 449.51M | 515.22M | 452.26M |
| Diluted EPS | 0.95 | 1.18 | 0.85 | 0.93 | 0.85 | 1.72 | 1.20 | 0.96 | 0.85 | 1.26 | 1.21 | 0.87 | 0.93 | 0.84 | 0.69 | 0.94 | 1.12 | 0.85 | 0.62 | -0.02 | 0.38 | 0.81 | 0.82 | 0.85 | 0.93 | 2.12 | 0.64 | 0.82 | 1.06 | 0.87 | 0.82 | 1.09 | 0.92 | 0.91 | 1.04 | 1.00 | 1.28 | 1.13 | 1.31 | 1.15 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.71B | 4.43B | 4.72B | 5.16B | 5.82B | 6.41B | 7.13B | 7.21B | 7.65B | 7.68B | 7.69B | 7.90B | 8.10B | - | 11.22B | 12.11B | 13.69B | 14.64B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.85B | 1.88B | 2.39B | 2.41B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 130.37M | 127.46M | 126.91M | 126.89M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.72B | 1.75B | 2.26B | 2.28B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 334.73M | 370.56M | 509.92M | 495.76M |
| Net Income | 281.14M | 309.06M | 446.40M | 391.21M | 510.59M | 499.93M | 648.88M | 503.69M | 601.92M | 549.09M | 640.75M | 681.94M | 530.67M | - | 1.38B | 1.38B | 1.76B | 1.78B |
| Diluted EPS | 1.62 | 1.86 | 2.88 | 2.69 | 3.56 | 3.55 | 4.86 | 3.87 | 4.68 | 2.84 | 3.33 | 3.52 | 1.87 | - | 3.29 | 3.37 | 4.36 | 4.45 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 17.33B | 17.53B | 18.40B | 20.16B | 20.55B | 21.72B | 21.73B | 23.36B | 24.30B | 24.90B | 26.66B | 28.61B | - | 33.86B | 37.20B | 40.57B | 44.07B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash & Equivalents | 951.86M | 1.13B | 515.43M | 642.95M | 911.74M | 839.74M | 839.74M | 674.44M | 763.63M | 795.28M | 950.47M | 817.60M | 1.02B | 2.37B | - | 1.45B | 1.36B | 1.97B | 2.54B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.20B | 6.95B | 6.88B | 6.97B |
| Total Liabilities | - | - | 13.73B | 13.82B | 14.44B | 15.82B | 16.18B | 17.09B | 17.10B | 18.28B | 18.85B | 19.42B | 20.54B | 22.28B | - | 27.09B | 29.73B | 32.16B | 34.36B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.83B | 2.84B | 2.84B | 2.84B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.84B | 2.84B | 2.84B | 2.84B |
| Total Equity | - | - | 3.60B | 3.70B | 3.95B | 4.31B | 4.34B | 4.59B | 4.60B | 5.05B | 5.41B | 5.44B | 6.07B | 6.31B | - | 6.75B | 7.46B | 8.40B | 9.70B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 793.52M | 793.52M | 793.52M | 793.52M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.55B | 316.05M | 451.32M | 670.28M | 675.46M | 819.80M | 734.85M | 881.30M | 848.38M | 710.88M | 620.20M | 1.14B | 1.62B | 2.18B | 2.57B | 2.93B | 3.68B | 3.58B |
| Investing Cash Flow | -614.56M | -1.12B | 37.35M | -204.27M | -775.07M | -545.36M | -808.31M | -170.76M | -794.49M | -333.46M | -714.24M | -424.87M | 119.70M | -2.99B | -1.89B | -1.96B | -2.18B | -2.03B |
| Financing Cash Flow | -663.29M | 173.38M | -359.07M | -195.21M | 97.19M | -330.26M | -69.77M | -555.32M | -6.93M | -235.09M | -7.40M | -513.19M | -397.84M | 5.83M | -771.99M | -1.06B | -852.49M | -1.03B |
| Capital Expenditure | -78.95M | -30.45M | -49.60M | -45.32M | -40.56M | -63.15M | -41.96M | -63.56M | -50.83M | -115.72M | -49.86M | -60.46M | - | - | -52.68M | -53.08M | -105.62M | -169.99M |
| Free Cash Flow | 1.47B | 285.60M | 401.71M | 624.96M | 634.90M | 756.65M | 692.89M | 817.74M | 797.55M | 595.16M | 570.34M | 1.08B | - | - | 2.52B | 2.88B | 3.57B | 3.41B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -94.74M | -95.22M | 641.39M | 526.83M |
| Share Buybacks | 553.28M | 147.14M | 471.01M | 187.16M | 127.66M | 166.47M | 238.93M | 223.65M | 132.39M | 47.81M | 24.75M | 18.23M | 346.36M | 122.43M | 94.14M | 537.16M | 303.65M | 270.22M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.5% | 15.5% | 17.5% | 16.4% |
| Net Margin % | 6.0% | 7.0% | 9.4% | 7.6% | 8.8% | 7.8% | 9.1% | 7.0% | 7.9% | 7.1% | 8.3% | 8.6% | 6.6% | - | 12.3% | 11.4% | 12.8% | 12.2% |
| ROE % | - | 8.6% | 12.1% | 9.9% | 11.9% | 11.5% | 14.1% | 10.9% | 11.9% | 10.1% | 11.8% | 11.2% | 8.4% | - | 20.5% | 18.5% | 20.9% | 18.3% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Mitsui Sumitomo Insurance Co Ltd | 15.83% | 58.78M | $4.02B |
| 2 | Blackrock Inc. | 5.91% | 21.93M | $1.50B |
| 3 | Vanguard Capital Management LLC | 5.03% | 18.69M | $1.28B |
| 4 | Vanguard Portfolio Management LLC | 3.92% | 14.55M | $995.87M |
| 5 | State Street Corporation | 3.81% | 14.13M | $966.83M |
| 6 | Geode Capital Management, LLC | 2.23% | 8.27M | $565.91M |
| 7 | Morgan Stanley | 2.22% | 8.25M | $564.82M |
| 8 | Kayne Anderson Rudnick Investment Management LLC | 1.72% | 6.38M | $436.45M |
| 9 | Invesco Ltd. | 1.35% | 5.03M | $344.14M |
| 10 | Goldman Sachs Group Inc | 1.12% | 4.16M | $284.59M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for WRB
WRB's Underwriting Discipline to Sustain Margins Amid Soft Pricing
W.R. Berkley's underwriting discipline and specialty expertise could help sustain strong margins as insurance pricing softens.
W. R. Berkley (WRB) Looks Fully Valued Following Berkley Meridian Launch
W. R. Berkley (WRB) has created Berkley Meridian, a specialty insurance business that combines Verus Specialty Insurance and Vela Insurance Services under shared leadership, with industry veteran Marlo M. Morrison appointed president. See o…
W. R. Berkley Stock: Is Wall Street Bullish or Bearish?
As W. R. Berkley has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
Why Is W.R. Berkley (WRB) Down 2.8% Since Last Earnings Report?
W.R. Berkley (WRB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
W. R. Berkley Corporation Forms Berkley Meridian
GREENWICH, Conn., August 18, 2026--W. R. Berkley Corporation (NYSE: WRB) today announced the formation of Berkley Meridian, a new specialty insurance business that will combine the strengths of Verus Specialty Insurance and Vela Insurance S…
CB Stock Trades at 1.62x Book Value: Is the Valuation Worth It?
Chubb's strong underwriting, commercial growth and investment income support earnings, while catastrophe losses and softer pricing pose risks.
WRB — Frequently Asked Questions
What is the current share price of W. R. Berkley Corporation (WRB)?
As of 2026-09-07 16:24 PDT, W. R. Berkley Corporation (WRB) trades at $69.56 on NYSE. Its 52-week range is $62.97 to $76.44.
What is the market capitalisation of WRB?
W. R. Berkley Corporation (WRB) has a market capitalisation of $25.82B on NYSE.
What is the P/E ratio of WRB?
WRB trades at a trailing price-to-earnings (P/E) ratio of 14.31. The industry average P/E is 14.52. Its price-to-book (P/B) ratio is 2.87.
Does WRB pay a dividend?
W. R. Berkley Corporation (WRB) currently offers a dividend yield of 0.55%.
What is the return on equity (ROE) of WRB?
WRB has a return on equity (ROE) of 20.21%.
Is WRB a good stock to buy?
This page provides a data-driven analysis of W. R. Berkley Corporation (WRB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.